Xilio Therapeutics
35 hedge funds and large institutions have $16.3M invested in Xilio Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.48%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
6
Increased
8
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$169K |
| 2 |
Morgan Stanley
New York
|
+$112K |
| 3 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
+$109K |
| 4 |
Two Sigma Investments
New York
|
+$53.1K |
| 5 |
Millennium Management
New York
|
+$37K |
